US going through rough patch but promising launches ahead Despite challenging years, the US remains a key driver for the company, contributing ~42% to total revenues. The company has strong pending pipeline comprises 110 (60 Para IV filings and 43 FTFs) including three NDAs under 505 (b)(2) route. We expect US sales to grow at a CAGR of 10% to...